Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer; PrTK03

Press/Media: Press / Media

Period	Oct 2 2018

Media coverage

Title	Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer; PrTK03
Media name/outlet	Clinical Trials.gov
Country	United States
Date	10/2/18
Persons	Michael A Liss, William Jones